Targeted delivery and imaging exploit the ability of heavy chain ferritin (H ferritin) to bind the transferrin receptor CD71, which is overexpressed in metabolically active iron‐demanding cells including tumor cells (Montemiglio et al. 2019). The gene discussed is TFRC; the disease is neoplasm.